{"id":"https://openalex.org/W2015238832","doi":"https://doi.org/10.1002/syn.890150406","title":"Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3\u2010methylfentanyl congeners, RTI\u201046144 and its enantiomers: Evidence for different binding domains","display_name":"Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3\u2010methylfentanyl congeners, RTI\u201046144 and its enantiomers: Evidence for different binding domains","publication_year":1993,"publication_date":"1993-12-01","ids":{"openalex":"https://openalex.org/W2015238832","doi":"https://doi.org/10.1002/syn.890150406","mag":"2015238832","pmid":"https://pubmed.ncbi.nlm.nih.gov/8153877"},"language":"en","primary_location":{"id":"doi:10.1002/syn.890150406","doi":"https://doi.org/10.1002/syn.890150406","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890150406","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Qi Ni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Ni","raw_affiliation_strings":["Clinical Psychopharmacology Section, NIDA, NIH, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, NIDA, NIH, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103501601","display_name":"Heng Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heng Xu","raw_affiliation_strings":["Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012476234","display_name":"John S. Partilla","orcid":"https://orcid.org/0000-0003-1023-5631","observed_orcids":["https://orcid.org/0000-0003-1023-5631"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. S. Partilla","raw_affiliation_strings":["Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112441808","display_name":"Peter A. Stark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. A. Stark","raw_affiliation_strings":["Research Triangle Institute, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Triangle Institute, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112366469","display_name":"F. Ivy Carroll","orcid":"https://orcid.org/0000-0001-9510-765X","observed_orcids":["https://orcid.org/0000-0001-9510-765X"]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. I. Carroll","raw_affiliation_strings":["Research Triangle Institute, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Triangle Institute, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070469235","display_name":"George A. Brine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. A. Brine","raw_affiliation_strings":["Research Triangle Institute, Research Triangle Park, North Carolina 27709"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Triangle Institute, Research Triangle Park, North Carolina 27709","institution_ids":["https://openalex.org/I180297670"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103446078","display_name":"Richard B. Rothman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R. B. Rothman","raw_affiliation_strings":["Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224","Clinical Psychopharmacology Section. Addiction Research Center, NIDA, NIH, P.O. Box 5180, Baltimore, MD 21224"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Psychopharmacology Section, Addiction Research Center, NIDA, NIH, Baltimore, Maryland 21224","institution_ids":["https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Clinical Psychopharmacology Section. Addiction Research Center, NIDA, NIH, P.O. Box 5180, Baltimore, MD 21224","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103446078"],"corresponding_institution_ids":["https://openalex.org/I1327069482"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.1287,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.38370347,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"4","first_page":"296","last_page":"306"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.4036000072956085,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.7570000290870667},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.7149999737739563},{"id":"https://openalex.org/keywords/binding-domain","display_name":"binding domain","score":0.4580000042915344},{"id":"https://openalex.org/keywords/dissociation-rate","display_name":"dissociation rate","score":0.5960000157356262},{"id":"https://openalex.org/keywords/enkephalin-binding","display_name":"enkephalin binding","score":0.625},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.5740000009536743},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7838070392608643},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7737570405006409},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.7057012319564819},{"id":"https://openalex.org/C2781072394","wikidata":"https://www.wikidata.org/wiki/Q407541","display_name":"Fentanyl","level":2,"score":0.5597596764564514},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5241111516952515},{"id":"https://openalex.org/C2779166228","wikidata":"https://www.wikidata.org/wiki/Q416827","display_name":"Etorphine","level":5,"score":0.5146840214729309},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4828070402145386},{"id":"https://openalex.org/C102931765","wikidata":"https://www.wikidata.org/wiki/Q189673","display_name":"Dissociation (chemistry)","level":2,"score":0.4784819483757019},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.4389258623123169},{"id":"https://openalex.org/C14397066","wikidata":"https://www.wikidata.org/wiki/Q14911924","display_name":"\u03bc-opioid receptor","level":4,"score":0.43712976574897766},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4351060390472412},{"id":"https://openalex.org/C74998103","wikidata":"https://www.wikidata.org/wiki/Q898254","display_name":"Dissociation constant","level":3,"score":0.41265034675598145},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4092719852924347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.300475537776947},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18488317728042603},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.06447246670722961},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.062143683433532715},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004745","descriptor_name":"Enkephalins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005048","descriptor_name":"Etorphine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005283","descriptor_name":"Fentanyl","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005283","descriptor_name":"Fentanyl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005283","descriptor_name":"Fentanyl","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005283","descriptor_name":"Fentanyl","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020875","descriptor_name":"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.890150406","doi":"https://doi.org/10.1002/syn.890150406","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890150406","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:8153877","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8153877","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6079999804496765,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W33523774","https://openalex.org/W1524561975","https://openalex.org/W1775749144","https://openalex.org/W1868989725","https://openalex.org/W1980043570","https://openalex.org/W1982272106","https://openalex.org/W1987437050","https://openalex.org/W1993477246","https://openalex.org/W1993902425","https://openalex.org/W2007178481","https://openalex.org/W2013907129","https://openalex.org/W2014106147","https://openalex.org/W2016275972","https://openalex.org/W2035388514","https://openalex.org/W2043813981","https://openalex.org/W2045112376","https://openalex.org/W2049488889","https://openalex.org/W2051082957","https://openalex.org/W2053547251","https://openalex.org/W2054119130","https://openalex.org/W2056368746","https://openalex.org/W2059512977","https://openalex.org/W2062665846","https://openalex.org/W2083495192","https://openalex.org/W2090052471","https://openalex.org/W2091869808","https://openalex.org/W2105738918","https://openalex.org/W2235051110","https://openalex.org/W2275009642","https://openalex.org/W2376012810","https://openalex.org/W2426254068","https://openalex.org/W2464166541"],"related_works":["https://openalex.org/W2091869808","https://openalex.org/W4237018136","https://openalex.org/W2019017702","https://openalex.org/W2053547251","https://openalex.org/W2899556369","https://openalex.org/W2778180507","https://openalex.org/W2078061947","https://openalex.org/W2034509722","https://openalex.org/W2004635453","https://openalex.org/W1982272106"],"abstract_inverted_index":{"Fentanyl":[0],"and":[1,41,98,115,127,150,173,250,275],"its":[2,99],"congeners":[3],"are":[4],"of":[5,10,19,22,34,49,59,86,105,137,155,185,195,206,241,246,254],"interest":[6],"not":[7],"only":[8],"because":[9,16],"their":[11],"clinical":[12],"applications,":[13],"but":[14,176],"also":[15],"certain":[17,234],"members":[18],"this":[20,122],"series":[21],"opioid":[23],"analgesics":[24],"exhibit":[25],"unique":[26],"properties,":[27],"such":[28],"as":[29,31,66,68,134,141],"acting":[30],"pseudoirreversible":[32,84,116,135,208,255],"inhibitors":[33,136,256],"mu":[35,63,87,139,220,235,248],"receptor":[36,88,140,249],"binding,":[37],"both":[38],"in":[39,42,54,182,271],"vitro":[40],"vivo.":[43],"Previous":[44],"studies":[45],"showed":[46],"that":[47,203,231,233,251],"pretreatment":[48],"membranes":[50],"with":[51,61,121,143],"(+)-cis-3-methylfentanyl":[52],"resulted":[53],"a":[55,167,226,266],"lower":[56],"affinity":[57,113],"interaction":[58],"[3H]ohmefentanyl":[60],"the":[62,80,91,106,138,153,161,183,186,193,204,207,214,219,242,247,252,258,262],"binding":[64,89,114,157,175,273],"site,":[65],"well":[67],"an":[69],"increased":[70],"dissociation":[71,162,188,194,276],"rate.":[72,163],"The":[73,118],"present":[74],"study":[75],"was":[76,109],"undertaken":[77],"to":[78,211,217,238,257,265,269],"determine":[79],"stereochemical":[81],"requirements":[82],"for":[83,111],"inhibition":[85,209],"using":[90],"methylfentanyl":[92],"congeners,":[93],"(+-)-cis-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-":[94],"phenylpropanamide":[95,125,131],"HCl":[96],"(RTI-4614-4)":[97],"four":[100],"resolved":[101],"enantiomers.":[102],"AR":[103],"configuration":[104],"2-hydroxy":[107],"group":[108],"essential":[110],"high":[112],"inhibition.":[117],"two":[119],"enantiomers":[120],"configuration,":[123],"1b((2R,3R,4S)-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-":[124],"oxolate)":[126],"1c":[128,129,151],"((2R,3S,4R)-N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-":[130],"HCl),":[132],"acted":[133],"labeled":[142],"[3H][D-Ala2-MePhe4,Gly-ol5]enkaphalin,":[144],"[3H]fentanyl":[145,172],"or":[146],"[3H]etorphine.":[147],"RTI-4614-4,":[148],"1b,":[149],"decreased":[152],"Bmax":[154],"[3H][D-Ala2-MaePhe4,Gly-ol5]enkepalin":[156],"sites":[158],"without":[159],"altering":[160],"These":[164],"drugs":[165],"had":[166],"lesser":[168],"effect":[169],"on":[170,213],"steady-state":[171,272],"[3H]etorphine":[174],"did":[177],"produce":[178],"statistically":[179],"significant":[180],"changes":[181,261],"parameters":[184],"two-component":[187],"model,":[189],"which":[190],"accurately":[191],"described":[192],"these":[196,200,224],"[3H]ligands.":[197],"Viewed":[198],"collectively,":[199],"data":[201],"indicate":[202],"mechanism":[205],"appears":[210],"depend":[212],"radioligand":[215],"used":[216],"label":[218],"receptor.":[221],"To":[222],"explain":[223],"data,":[225],"pseudoallosteric":[227],"model":[228],"is":[229],"proposed":[230],"postulates":[232],"ligands":[236],"bind":[237],"different":[239],"domains":[240,263],"drug":[243],"recognition":[244,259],"site":[245,260],"prebinding":[253],"available":[264],"radioligand,":[267],"leading":[268],"alterations":[270],"levels":[274],"kinetics.":[277]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}